| Medicare Palmetto | Billing and Coding: The Routine Costs of Investigational Chemotherapy Drugs Studied In a Qualifying Clinical Trial (53784) | 2020-08-12 |
| BCBS Florida Coverage Guidelines | Mifepristone (Korlym™) Oral (09-J1000-69) | 2020-07-15 |
| BCBS Florida Coverage Guidelines | Nintedanib (Ofev®) Oral Capsules (09-J2000-25) | 2020-07-15 |
| BCBS Highmark Penn Medicare Advantage | Idursulfase (Elaprase) | 2020-06-29 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Hospital Admission Provision (Benefits After Contract Termination) | 2020-06-01 |
| BCBS Highmark NY and West NY | Hospital Admission Provision (Benefits After Contract Termination) | 2020-06-01 |
| BCBS Highmark Delaware | Hospital Admission Provision (Benefits After Contract Termination) | 2020-06-01 |
| BCBS Highmark West Virginia | Hospital Admission Provision (Benefits After Contract Termination) | 2020-06-01 |
| BCBS Kansas | Myocardial Strain Imaging | 2020-05-18 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Clinical Trials | 2020-04-27 |